The 9th edition of Canada’s flagship applied AI summit returns with 60 expert-led sessions, case studies, hands-on workshops, ...

Collectively, the data from in vitro and in vivo studies using FUS, TDP-43, and C9orf72 models demonstrate that hUPF1 holds significant potential for treating the majority of patients with ALS and ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...

Cybersecurity research company NETSCOUT that looks at results of its newest Threat Intelligence Report specifically for North ...

Technological opportunities typically come with a certain amount of risk – and generative AI adoption is no exception ...

Twenty One Capital’s Bitcoin venture sparks debate over institutional influence and its impact on Bitcoin’s decentralized ...

The scope of the presented studies is somewhat limited, as they primarily focus on evaluating the phenotypic changes in cardiac innervation following the loss of various Slit or Robo genes.

CyberKnight has partnered with Ridge Security, the World’s First Al-powered Offensive Security Validation Platform ...

In this valuable study, the authors demonstrate that TCF7L2 plays a role in the pathogenesis of cachexia in a mouse model of GI cancer. The results are solid, although future studies will need further ...

MongoDB’s $220 million Voyage AI deal is the only major acquisition in the company’s history. We expect the acquisition of Voyage AI to more than triple MongoDB’s goodwill balance of $70 million as of ...

Nation-state intrusions. Deepfake-ready malware. AI-powered influence ops. New CVEs, old threats reborn, and spyware with ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...